228 related articles for article (PubMed ID: 12715765)
1. User fees and medical device reviews.
Lewis C
FDA Consum; 2003; 37(2):18-9. PubMed ID: 12715765
[No Abstract] [Full Text] [Related]
2. FDA user fee and Modernisation Act.
Donawa M
Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
[TBL] [Abstract][Full Text] [Related]
3. Medical device technology user fees.
Bailey PG
Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834
[TBL] [Abstract][Full Text] [Related]
4. Will new FDA rules hasten device approval?
Hosp Mater Manage; 2003 Jul; 28(7):2, 16. PubMed ID: 12889277
[No Abstract] [Full Text] [Related]
5. United States laws under review.
Leahey M
Med Device Technol; 2007; 18(3):44-5. PubMed ID: 17585722
[TBL] [Abstract][Full Text] [Related]
6. User fees and beyond--the FDA Safety and Innovation Act of 2012.
Kramer DB; Kesselheim AS
N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
[No Abstract] [Full Text] [Related]
7. Cosmetic medical devices and their FDA regulation.
Newburger AE
Arch Dermatol; 2006 Feb; 142(2):225-8. PubMed ID: 16490851
[No Abstract] [Full Text] [Related]
8. FDA user fees approved.
Clin Pharm; 1993 Jan; 12(1):3. PubMed ID: 8428431
[No Abstract] [Full Text] [Related]
9. Watchdog group says "massive lobbying effort" by medical device industry threatens public health.
Lenzer J
BMJ; 2012 Feb; 344():e1521. PubMed ID: 22374926
[No Abstract] [Full Text] [Related]
10. FDA user fees and innovation.
Somberg J
Am J Ther; 2008; 15(2):97. PubMed ID: 18356626
[No Abstract] [Full Text] [Related]
11. Judicial review of FDA preemption determinations.
Frost A
Food Drug Law J; 1999; 54(3):367-88. PubMed ID: 11797704
[No Abstract] [Full Text] [Related]
12. Devices and the food and drug administration.
Phillips SJ; Phillips RS
Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
[No Abstract] [Full Text] [Related]
13. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
Burkhart CG
J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
[No Abstract] [Full Text] [Related]
14. Pharmaceuticals and medical devices: medical devices.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-23. PubMed ID: 19297720
[No Abstract] [Full Text] [Related]
15. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
Lang L
Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
[No Abstract] [Full Text] [Related]
16. U.S. medical device reporting: who is responsible?
Donawa M
Med Device Technol; 2005 Apr; 16(3):27-9. PubMed ID: 15871421
[TBL] [Abstract][Full Text] [Related]
17. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
18. User fees to fund faster reviews.
Henkel J
FDA Consum; 1993 Oct; 27(8):19-21. PubMed ID: 10129049
[No Abstract] [Full Text] [Related]
19. FDA panel gives cautious signal to summit.
Moretti M
J Refract Corneal Surg; 1994; 10(6):613-4. PubMed ID: 7719529
[No Abstract] [Full Text] [Related]
20. The FDA and the spine surgeon.
Ducker TB
J Spinal Disord; 1999 Aug; 12(4):277-9. PubMed ID: 10451041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
